Filing Details

Accession Number:
0001474506-21-000159
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-04 20:09:49
Reporting Period:
2021-11-02
Accepted Time:
2021-11-04 20:09:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267602 Alimera Sciences Inc ALIM Pharmaceutical Preparations (2834) 200028718
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1344927 R James Largent 4040 Macarthur Boulevard
Suite 240
Newport Beach CA 92660
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-03 10,000 $4.31 13,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2021-11-02 6,000 $0.00 6,000 $4.05
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
6,000 2031-11-01 No 4 A Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.11 to $4.53, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
  2. Vests in full on June 15, 2022, provided the Reporting Person provides continuous service to the Issuer through such date.